VEGFA and hepatocellular carcinoma: In this study, Ad-ANGPTL4 treatment significantly suppressed the formation of new vessels in the tumor through repressing the expression of angiogenic factor VEGF and suppressing the activation of Raf-MEK-Erk signaling pathway, suggesting an anti-angiogenic effect of ANGPTL4 on HCC.